DRUG DISCOVERY FEATURED ARTICLES & APPLICATIONS

• 

  Drug Development: Take The Guesswork Out Of Crystallization

  Batch-to-batch variability during the crystallization of active pharmaceutical ingredients (API) can have a profound impact on both safety and efficacy of the final drug formulation, and direct business and cost  implications for both the API manufacturer and downstream drug-formulation partners.

• The Urgent Need For Qualified Transportation Providers

  Given the high cost of conducting global clinical trials and the even higher cost of failure, regulatory agencies and pharmaceutical companies alike now demand that every party involved in the pharmaceutical supply chain — transportation and logistics providers included — conform to GxP guidelines. By World Courier

• Inflammation And The New Drug Development Paradigm

  Opportunities abound for new treatments for inflammatory diseases, which afflict millions of people. Upward spiraling development costs, however, impede progress and delay relief for patients suffering from such debilitating diseases. By Thomas Vihtelic, DVM, PhD, MPI Research

• Vaccine Potential And Preclinical Development Needs

  Few medical advances have made as large an impact on world health as vaccines. Globally, Vaccines prevent approximately 10.5 million cases of infectious illness each year. 2.5 million child deaths are prevented from diphtheria, tetanus, pertussis, and measles annually through immunization (BIO). Despite these facts, infectious diseases are still the second leading cause of death worldwide, and new infectious diseases continue to emerge. By Stephene Rose; Senior Study Director at MPI Research

• Automation Of Cell Staining

  Automation with the Biomek 4000 platform can improve the throughput and reproducibility of conventional staining of adherent cells. Applicability is demonstrated using mouse embryonic stem cells (mESCs) to detect the expression of developmental antigens in fixed cells following differentiation to cardiomyocytes which is relevant to stem cell biology research. By Amy N. Yoder and Li Liu, Beckman Coulter Life Sciences

LATEST NEWS

• DPx Launches As Global Provider Of Pharmaceutical Services, Fine Chemicals And Proprietary Technologies

  DPx Holdings B.V. (DPx), privately owned by JLL Partners and Royal DSM, recently launched as a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical and related industries.

• Eisai And Biogen Idec Enter Collaboration To Develop And Commercialize Alzheimer’s Disease Treatments
• Enanta Pharmaceuticals Announces New Data Presented On Protease Inhibitor ABT-493 At The 21^st Conference On Retroviruses And Opportunistic Infections (CROI)
• GE Healthcare Invests In FISH Technologies For Leukemia And Lymphoma Testing
• Blockade Medical Announces 510(k) Clearance And CE Mark Of Two New Additions To The Barricade Coil System

FEATURED PRODUCTS AND SERVICES

Environmental Monitoring Management Software

BioTrends Data Management Software is a novel electronic environmental monitoring management tool that addresses many of the challenges that pharmaceutical and biotechnology manufacturing facilities face today.

Mueller MES-325-6 WFI Distillation Unit (Private Treaty Sale)

Mueller MES-325-6 WFI Distillation Unit (Private Treaty Sale) By GoIndustry DoveBid

HPLC Pump

The L-7100 HPLC Pump provides consistent stable flow for critical analysis, using microprocessor optimization that eliminates pulses...

Nucleic Acid Fragment Analysis System

The WAVE-HS DNA Analysis System provides an automated turn-key approach for scanning tumor samples

Drug Safety Audits Software

Without a means to track and schedule, drug safety audits tend to be performed on an irregular basis, typically resulting in disconnected audits with recommendations that not followed up on.

ARCHIVED NEWSLETTER

• 03.07.14 -- Investment In FISH Technologies For Leukemia And Lymphoma Testing
• 02.07.14 -- Advanced Genetic Technique Yields Novel Antibiotic From Ocean Bacteria
• 01.03.14 -- Five Potential Cancer Targets For Antibody Drug Conjugate Therapy Discovered
• 12.06.13 -- Report: Pharma Should Factor Medication Adherence Into Drug Development
• 11.01.13 -- Strategic Alliance Formed To Fight Counterfeit Drugs